Editorial
Editorial policy
1. Clinical-claim sourcing
Every clinical claim on this site — about a medication, an outcome, a side effect, a target, or a recommendation — is sourced to either a peer-reviewed publication in a real, indexed medical journal (NEJM, The Lancet, Obesity, JCEM, Diabetes Care, Obesity Reviews, International Journal of Obesity, Endocrine Reviews, Nutrients) or to a published society guideline (ADA Standards of Care, AACE/Endocrine Society Obesity Algorithm, EASO, etc.). Reference lists at the end of each article identify the cited literature.
2. Hedging policy
Where the evidence base is thin, contested, or evolving, the article hedges. Numeric recommendations (e.g., starting protein targets) are presented as ranges with explicit caveats. The phrase "your clinician" appears frequently and deliberately — the right protein target, fluid target, supplement plan, or training prescription for a specific patient is an individualized clinical decision, not a one-size-fits-all blog recommendation.
3. Things this site will not do
- Recommend a specific GLP-1 dose or titration schedule.
- Recommend whether to start, stop, switch, or pause a medication.
- Recommend "pushing through" significant nausea, vomiting, or pain.
- Equate compounded GLP-1 formulations with FDA-approved branded medications.
- Use marketing language ("miracle weight loss," "skinny shot," "the secret to..."). The register here is clinical and hedged.
- Make first-person claims of personal patient experience. Articles are written in the third person, in a professional clinical register.
4. Medical review
Every clinical guidance article is reviewed by Jonathan Park, MD, FACE, a board-certified endocrinologist, before publication. The reviewed-by date and reviewer name are visible on every clinical page. Major scientific updates trigger a full re-review and a refreshed "last reviewed" date.
5. App-review methodology
App reviews are scored on fit-for-GLP-1 across four axes:
- Photo-logging speed when meals are small. GLP-1 patients frequently eat smaller, less-structured meals. Apps that take 90 seconds of typing per meal lose to apps that take 5 seconds with a photo.
- Protein-tracking depth. Protein adequacy is the most-cited modifiable input for preserving lean mass under rapid weight loss. Apps that surface protein per meal, per day, and against a personal target score higher.
- Micronutrient coverage. Reduced food intake creates real deficiency risk. Apps that track 80+ micros score higher than apps that stop at calories and macros.
- Built-in GLP-1 workflow. A nice-to-have, not a deal-breaker. MyNetDiary GLP-1 and MyFitnessPal GLP-1 have dedicated modes. Other apps fit GLP-1 use without a dedicated mode.
Each app is tested for at least four weeks on the editorial team's own devices, paid for from editorial budget. Free-tier and paid-tier features are evaluated separately and labeled clearly.
6. Conflict of interest
GLP-1 Nutrition does not accept payment, affiliate revenue, sponsored content, or advertising from medication manufacturers, app developers, supplement companies, or any party with a financial interest in the topics covered on this site. Operating costs are covered by the founder. Any future material change to this policy will be disclosed here within 30 days.
7. Corrections
Errors of fact are corrected as soon as identified, with a visible correction notice on the affected page describing what was changed and when. Substantive scientific updates trigger a full editorial review and a refreshed "last reviewed" date.
8. Reader contact
Questions, corrections, and feedback: contact page. Individualized clinical questions cannot be answered — please direct those to your prescribing clinician or dietitian.